Jefferies Group’s Novo Nordisk NVO Stock Holding History

Jefferies Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-139,000	Closed	-$3.64M	–	2775
2019 Q1	$3.64M	Buy	+139,000	New	+$3.42M	0.03%	575
2018 Q3	–	Sell	-311,800	Closed	-$7.19M	–	2650
2018 Q2	$7.19M	Buy	+311,800	New	+$7.41M	0.04%	366
2018 Q1	–	Sell	-8,600	Closed	-$231K	–	2567
2017 Q4	$231K	Buy	+8,600	New	+$219K	﹤0.01%	2141
2014 Q4	–	Sell	-600	Closed	-$14K	–	2234
2014 Q3	$14K	Buy	+600	New	+$13.8K	﹤0.01%	2047
2014 Q1	–	Sell	-713,000	Closed	-$13.2M	–	2279
2013 Q4	$13.2M	Buy	+713,000	New	+$12.4M	0.08%	125
2013 Q3	–	Sell	-1,040,000	Closed	-$16.1M	–	2110
2013 Q2	$16.1M	Buy	+1,040,000	New	+$17.3M	0.17%	90

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Jefferies Group's NVO Position: Q1 2020 in Review

Jefferies Group sold out of Novo Nordisk (NVO) in Q1 2020, closing a stake of 18,358 shares — an estimated $531K sold.

Jefferies Group first reported a position in NVO in Q3 2013 and held it in 18 quarters. The position peaked at $6.86M in Q1 2015. 644 funds tracked by Wall St. Rank hold NVO as of Q1 2020.

Jefferies Group reported no remaining Novo Nordisk position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 18,358 Novo Nordisk shares in Q1 2020, an estimated $531K.
Jefferies Group first reported a position in Novo Nordisk in Q3 2013 and held it in 18 quarters.
Jefferies Group's Novo Nordisk position peaked at $6.86M in Q1 2015.
644 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.